By Sheri Kasprzak
New York, Sept. 16 - York Pharma plc said it closed a private placement for £5 million.
The company sold 4,716,982 shares at 106p each to institutional and other investors.
The proceeds from the offering will be used to acquire additional prescription dermatology products, establish and build the company's U.K. sales and marketing capability and develop clinical indications for its lead product Abasol.
Based in Hertfordshire, England, York Pharma is a pharmaceutical company focused on dermatology products.
| Issuer: | York Pharma plc
|
| Issue: | Stock
|
| Amount: | £5 million
|
| Shares: | 4,716,982
|
| Price: | 106p
|
| Warrants: | No
|
| Settlement date: | Sept. 16
|
| Stock price: | 114p at close Sept. 15
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
